dihexa cancer risk hgf c-met Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF-c-Met Axis in Head – Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress dihexa hgf c met cancer risk Role of the HGF c MET tyrosine kinase inhibitors in Molecular mechanism(s) of regulation(s) of HGF c MET: A Promising Therapeutic Target in the Digestive System Cancers Frontiers The Function of the HGF c Met Axis in Hepatocellular Carcinoma Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




